Butrón-Bris, B, Llamas-Velasco, M, Ovejero-Benito, MC, Santos-Juanes, J, Martínez-López, A, Ruiz-Villaverde, R, Roustan, G, Baniandrés, O, Izu-Belloso, R, de la Cueva, P, Sahuquillo-Torralba, A, Gónzalez-Quesada, A, Vilarrasa-Rull, E, Pujol-Montcusi, J, García-Martínez, J, Navares, M, Palomar-Moreno, I, Novalbos, J, Abad-Santos, F, Daudén, E, de la Fuente, H. Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice. EXPERIMENTAL DERMATOLOGY. 2024; 33(8)DOI:10.1111/exd.15152. PMID:39081053. IF:3.100(Q2/3D).

Rusinol, L, Puig, L. A Narrative Review of the IL-18 and IL-37 Implications in the Pathogenesis of Atopic Dermatitis and Psoriasis: Prospective Treatment Targets. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158437. PMID:39126010. IF:4.900(Q1/3D).

Carmona-Rocha, E, Rusiñol, L, Garcia-Melendo, C, Iznardo, H, Mozos, A, López-Sánchez, C, Yélamos, O. Lentigo maligna: a comprehensive review on diagnosis and treatment. Italian Journal of Dermatology and Venereology. 2024; 159(4)DOI:10.23736/S2784-8671.24.07837-X. PMID:39069838. IF:2.600(Q2/4D).

Choon, SE, van de Kerkhof, P, Gudjonsson, JE, de la Cruz, C, Barker, J, Morita, A, Romiti, R, Affandi, AM, Asawanonda, P, Burden, AD, Gonzalez, C, Marrakchi, S, Mowla, MR, Okubo, Y, Oon, HH, Terui, T, Tsai, TF, Callis-Duffin, K, Fujita, H, Jo, SJ, Merola, J, Mrowietz, U, PUIG SANZ, LUIS, Thaçi, D, Velásquez, M, Augustine, M, El Sayed, M, Navarini, AA, Pink, A, Prinz, J, Turki, H, Magalhaes, R, Capon, F, Bachelez, H. International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council. JAMA Dermatology. 2024; DOI:10.1001/jamadermatol.2024.0915. PMID:38691347. IF:11.000(Q1/1D).